HOME › DRUGS › ROMIPLOSTIM
ACTIVE SUBSTANCE / INN

ROMIPLOSTIM

Brand name(s): Nplate, NPLATE
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Purpura, Thrombocytopenic, Idiopathic
BLA125268
ACTIVE SUBSTANCE
Romiplostim
REGULATORS
FDA · EMA
SPONSORS / MAH
AMGEN, Amgen Europe B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NPLATEBLA125268AMGENPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NplateAmgen Europe B.V.Authorised04/02/2009Purpura, Thrombocytopenic, Idiopathic

FULL INTELLIGENCE ON ROMIPLOSTIM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →